Care of the Stroke Patient: Routine Management to Lifesaving Treatment Options

Elsevier BV - Tập 8 Số 3 - Trang 414-424 - 2011
George Α. Lopez1, Arash Afshinnik2, Owen Samuels2
1Department of Neurology, Houston Health Science Center, University of Texas, 77030, Houston, TX, USA
2Division of Neurosciences Critical Care, Emory Healthcare, Emory University, Atlanta, GA, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Alberts, 2000, The Brain Attack Coalition. Recommendations for the establishment of primary stroke centers, JAMA, 282, 3102, 10.1001/jama.283.23.3102

Garraway, 1985, Stroke rehabilitation units: concepts, evaluation, and unresolved issues, Stroke, 16, 178, 10.1161/01.STR.16.2.178

Stroke Unit Trialists' Collaboration, 1997, How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials, Stroke, 28, 2139, 10.1161/01.STR.28.11.2139

Seenan, 2007, Stroke units in their natural habitat, Systematic review of observational studies. Stroke, 38, 1886

Stroke Unit Trialists' Collaboration, 1997, Collaborative systematic review of the randomized trials of organized inpatient (stroke unit) care after stroke, BMJ, 314, 1151, 10.1136/bmj.314.7088.1151

Stroke Unit Trialists' Collaboration. Organized inpatient (stroke unit) care for stroke. (Cochrane Review). In: The Cochrane Library, 2007:CD000197.

Diringer, 1999, Predictors of acute hospital costs for treatment of ischemic stroke in an academic center, Stroke, 30, 724, 10.1161/01.STR.30.4.724

Ang, 2003, Patient outcomes and length of stay in a stroke unit offering both acute and rehabilitation services, MJA, 178, 333

Taylor, 2006, Effectiveness of a clinical pathway for acute stroke care in a district general hospital: an audit, BMC Health Serv Res, 6, 16, 10.1186/1472-6963-6-16

Kwan, 2003, In-hospital care pathways for stroke: A Cochrane Systematic Review, Stroke, 587, 10.1161/01.STR.0000054673.28010.1B

Rudd, 2004, Health policy and outcome research in stroke, Stroke, 35, 397, 10.1161/01.STR.0000115935.76330.24

Ronning, 2001, The benefit of an acute stroke unit in patients with intracerebralhaemorrhage: a controlled trial, J Neurol Neurosurg Psychiatry, 70, 631, 10.1136/jnnp.70.5.631

Kamphuisen, 2005, Prevention of venous thromboembolism after acute ischemic stroke, J Thromb Haemost, 3, 1187, 10.1111/j.1538-7836.2005.01443.x

Prins, 1989, Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients, Haemostasis, 19, 245

Pambianco, 1995, Deep venous thrombosis: prevention in stroke patients during rehabilitation, Arch Phy Med Rehabil, 76, 324, 10.1016/S0003-9993(95)80657-1

Kelly, 2004, Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging, Stroke, 35, 2320, 10.1161/01.STR.0000140741.13279.4f

Geerts, 2004, Prevention of venous thromboembolism: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy, Chest, 126, 338S, 10.1378/chest.126.3_suppl.338S

CAST (Chinese Acute Stroke Trial) Collaborative Group, 1997, CAST: randomized placebo controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke, Lancet, 349, 1641, 10.1016/S0140-6736(97)04010-5

International Stroke Trial Collaborative Group, 1997, The international Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke, Lancet, 349, 1569, 10.1016/S0140-6736(97)04011-7

Sandercock PAG, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke (Cochrane Review). The Cochrane Library Issue 4. Article CD000029.

McCarthy, 1986, Low dose subcutaneous heparin in the prevention of deep vein thrombosis and pulmonary emboli following acute stroke, Age Ageing, 15, 84, 10.1093/ageing/15.2.84

The Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators, 1998, Low molecular weight heparinoid ORG 10172 (danaparoid), and outcome after acute ischemic stroke, JAMA, 279, 1265, 10.1001/jama.279.16.1265

Sandercock PAG, 2005, Low molecular weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000119.pub2

Sandercock PAG, 2008, Low molecular weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000119.pub3

Sandercock PAG, Counsell C, Tseng MC. Low molecular weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2011, Issue 4. Art. No. CD000119.

Amaragiri SV, Lees TA. Elastic compression stockings for the prevention of deep vein thrombosis (Cochrane Review). The Cochrane Library Issue 4. Article CD0001484.

Naccarato, 2010, Physical methods for preventing deep vein thrombosis in stroke, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001922.pub3

Godoy, 2010, Treating hyperglycemia in neurocritical patients: benefits and perils, Neurocrit Care, 13, 425, 10.1007/s12028-010-9404-8

Melamed, 1976, Reactive hyperglycemia in patients with acute stroke, J NeurolSci, 29, 267

Capes, 2001, Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview, Stroke, 32, 2426, 10.1161/hs1001.096194

Yong, 2008, Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II Trial, Stroke, 39, 2749, 10.1161/STROKEAHA.108.514307

Allport, 2006, Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring, Diabetes Care, 29, 1839, 10.2337/dc06-0204

Matz, 2006, Disorders of glucose metabolism in acute stroke patients: an underrecognized problem, Diabetes Care, 29, 792, 10.2337/diacare.29.04.06.dc05-1818

Gauna, 2005, Pituitary function during severe and life threatening illnesses, Pituitary, 8, 213, 10.1007/s11102-006-6043-3

Kruyt, 2010, Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management, Nat Rev Neurol, 6, 145, 10.1038/nrneurol.2009.231

Baird, 2003, Persistent hyperglycemia is independently associated with infarct expansion and worse clinical outcome, Stroke, 34, 2208, 10.1161/01.STR.0000085087.41330.FF

Fuentes, 2009, The prognostic value of capillary glucose levels in acute stroke, Stroke, 40, 562, 10.1161/STROKEAHA.108.519926

Bruno, 2002, Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial, Neurology, 59, 669, 10.1212/WNL.59.5.669

Gentile, 2006, Decreased mortality by normalizing blood glucose after acute ischemic stroke, Acad Emerg Med, 13, 174, 10.1197/j.aem.2005.08.009

Gray, 2007, Glucose-potassium-insulin infusions in the management of post-stroke hyperglycemia: the UK Glucose Insulin in Stroke Trial (GIST-UK), Lancet, 6, 397, 10.1016/S1474-4422(07)70080-7

Johnston, 2009, Glucose regulation in acute stroke patients (GRASP) Trial, A randomized pilot trial. Stroke, 40, 3804

Bruno, 2008, Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial, Stroke, 39, 384, 10.1161/STROKEAHA.107.493544

Diringer, 2004, Osmotic therapy: fact and fiction, Neurocrit Care, 1, 219, 10.1385/NCC:1:2:219

Gullans, 1993, Control of brain volume during hyperosmolar and hypoosmolar conditions, Annu Rev Med, 44, 289, 10.1146/annurev.me.44.020193.001445

Bereczki, 2007, Mannitol for acute stroke, Cochrane Database Syst Rev, 10.1002/14651858.CD001153.pub2

Videen, 2001, Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke, Neurology, 57, 2120, 10.1212/WNL.57.11.2120

Adrogue, 2000, Hypernatremia, N Engl J Med, 342, 1493, 10.1056/NEJM200005183422006

Lien, 1990, Effects of hypernatremia on organic brain osmoles, J Clin Invest, 85, 1427, 10.1172/JCI114587

Rudehill, 1993, Pharmacokinetics and effects of mannitol on hemodynamics, blood and cerebrospinal fluid electrolytes, and osmolality during intracranial surgery, J Neurosurg Anesthesiol, 5, 4, 10.1097/00008506-199301000-00002

Karibe, 1995, Use of mild intra-ischemic hypothermia versus mannitol to reduce infarct size after temporary middle cerebral artery occlusion in rats, J Neurosurg, 83, 93, 10.3171/jns.1995.83.1.0093

Shirane, 1992, Effect of mannitol on local cerebral blood flow after temporary complete cerebral ischemia in rats, J Neurosurg, 76, 486, 10.3171/jns.1992.76.3.0486

Wise, 1962, The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebro-spinal-fluid pressure, J Neurosurg, 19, 1038, 10.3171/jns.1962.19.12.1038

Bereczki, 2003, Mannitol use in acute stroke: case fatality at 30 days and 1 year, Stroke, 34, 1730, 10.1161/01.STR.0000078658.52316.E8

Adams, 2007, Stroke, 38, 1655, 10.1161/STROKEAHA.107.181486

Olsen, 2003, European Stroke Initiative Recommendations for Stroke Management-update 2003, Cerebrovasc Dis, 16, 311, 10.1159/000072554

Weed, 1919, Experimental alteration of brain bulk, Am J Physiol, 48, 531, 10.1152/ajplegacy.1919.48.4.531

Vassar, 1993, A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients, Arch Surg, 128, 1003, 10.1001/archsurg.1993.01420210067009

Wade, 1997, Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension, J Trauma, 42, S61, 10.1097/00005373-199705001-00011

Pascual, 1992, Resuscitation of intraoperative hypovolemia: a comparison of normal saline and hyperosmotic/hyperoncotic solutions in swine, Crit Care Med, 20, 200, 10.1097/00003246-199202000-00009

Angle, 1998, Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression, J Trauma, 45, 7, 10.1097/00005373-199807000-00002

Angle, 1998, Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock, Shock, 9, 164, 10.1097/00024382-199803000-00002

Adams, 2007, Circulation, 115, e478, 10.1161/CIRCULATIONAHA.107.181486

Hanna, 1996, Prediction of worsening consciousness from edema after hemispheric infarction, J Stroke Cerebrovasc Dis, 6, 25, 10.1016/S1052-3057(96)80022-X

Hacke, 1996, “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs, Arch Neurol, 53, 309, 10.1001/archneur.1996.00550040037012

Vahedi, 2007, Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial), Stroke, 38, 2506, 10.1161/STROKEAHA.107.485235

Juttler, 2007, Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial, Stroke, 38, 2518, 10.1161/STROKEAHA.107.485649

Hofmeijer, 2009, Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial, Lancet Neurol, 8, 326, 10.1016/S1474-4422(09)70047-X

Vahedi, 2007, Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials, Lancet Neurol, 6, 215, 10.1016/S1474-4422(07)70036-4

Koh, 2000, Neuroimaging in deteriorating patients with cerebellar infarcts and mass effect, Stroke, 31, 2062, 10.1161/01.STR.31.9.2062

Gupta, 2004, Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review, Stroke, 35, 539, 10.1161/01.STR.0000109772.64650.18